Sign in
Active, not recruitingPhase 2

Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury

Key facts

Who runs it
Minneapolis Veterans Affairs Medical Center
Where
Minneapolis, United StatesSee the site
Trial code
Status
Active, not recruiting
Phase
Phase 2
People taking part
41 people enrolled
Started
Jul 2016
Ended
Sept 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Anodal Transcranial Direct Current Stimulation
  • Sham stimulation
Record updated
9 October 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Veterans enrolled at the Minneapolis Veterans Affairs (VA) Health Care System
  • Age of 18 and 65
  • Sustained a mild traumatic brain injury more than 1 year ago

Who cannot take part

  • Clinically unstable due to a hospitalization or medication change in the previous 4 weeks
  • Presence of a psychotic disorder
  • Mild substance use disorder in the last month
  • Moderate to Severe substance use disorder in the last six months
  • Have another existing neurological condition that impacts cognitive functioning
  • Have a medical condition that is incompatible with transcranial direct current stimulation
  • Severely depressed
  • Behavioral problems that prevent participation in a group intervention
  • Premorbid intellectual ability (IQ) below 70
  • Unable to provide informed consent
  • Have a guardian of person
  • Not fluent enough in English to understand testing procedures

Where in United States

  • Minneapolis Veterans Affairs Health Care SystemMinneapolis, United States

About the trial

What the trial wants to find out

The primary aim of this study is to assess the magnitude of transcranial direct current stimulation (tDCS) -induced cognitive and functional change in patients with mild traumatic brain injury. This study will also attempt to identify biomarkers associated with treatment response. Last, acceptability and tolerability of procedures will be assessed. To accomplish these aims, a randomized, double-blind, sham-controlled, parallel groups, pilot study will be conducted in which participants are assigned to 24 sessions of tDCS or sham stimulation offered concurrent with working memory training. Neural efficiency will be measured with electroencephalogram (EEG) pre and post-intervention.

The 2 groups in the trial

  • Transcranial Direct Current StimulationTreatment being tested

    Participants will receive 24 sessions (2 times a week) of anodal transcranial direct current stimulation concurrent with working memory training. Stimulation will be administered at 2 milliamps (mA) for 20 minutes over the left dorsal lateral prefrontal cortex.

    Treatment: Anodal Transcranial Direct Current Stimulation

  • ShamSham treatment, for comparison

    Participants will receive 24 sessions of working memory training. The experience of transcranial direct current stimulation will be simulated by administering 30 seconds of stimulation at the beginning of the session.

    Treatment: Sham stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 October 2025